← Eichor
Condition: Major Nerve Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Major Nerve

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT07480941Conditioning Electrical Stimulation to Improve Outcomes in Cubital Tunnel Syndrome
NA · 1 location(s) · University of Alberta · NCT053957155G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Phase 1/Phase 2 · 3 location(s) · Institute of Cancer Research, United Kingdom · NCT06630260Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune D
Phase 4 · 1 location(s) · Toyos Clinic · NCT06964269STARLITE for Unresectable High-Grade Gliomas
Phase 1 · 1 location(s) · University of Miami · NCT06428045Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
Phase 1 · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT00804154Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Phase 1/Phase 2 · 1 location(s) · Tianjin Medical University General Hospital · NCT07022197C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT040997975G-PEARL: Paxalisib in Malignant Brain Tumours
Phase 1/Phase 2 · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT07391215TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS
NA · 1 location(s) · Jiani Wu · NCT06287970A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refra
EARLY_Phase 1 · 1 location(s) · Children's National Research Institute · NCT07017816A Phase 2 Study of HX301 in Patients with High-grade Giloma
Phase 1/Phase 2 · 1 location(s) · Hangzhou Hanx Biopharmaceuticals, Ltd. · NCT06703255MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
Phase 1/Phase 2 · 3 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT06712875Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
Phase 2 · 1 location(s) · Massachusetts General Hospital · NCT05684692Venous Thromboembolism Prevention in Outpatients With Glioma
Phase 2 · 1 location(s) · University of Vermont Medical Center · NCT05683808Screening for Prognostic Biomarkers of Severe Bell's Palsy in Adults
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT05582915Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
Phase 1/Phase 2 · 1 location(s) · Emory University · NCT04590664A Study of 177Lu-PSMA-617 in People With Gliomas
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07223034A Novel Target Delineation Scheme in High-grade Glioma Patients: a Randomized Single-blind Clinical Trial
NA · 1 location(s) · Zhujiang Hospital · NCT06215495Study of LGW16-03 To Identify Nerves
Phase 1 · 1 location(s) · Eric R. Henderson · NCT07385430Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
Phase 1 · 1 location(s) · Henry Ford Health System · NCT05686798Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
Phase 1 · 1 location(s) · Plus Therapeutics · NCT05460507Atovaquone Combined With Radiation in Children With Malignant Brain Tumors
Phase 1 · 2 location(s) · Emory University · NCT06624371ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
Phase 1 · 1 location(s) · Mayo Clinic · NCT05917145Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT07468136The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06146725Dabrafenib and/or Trametinib Rollover Study
Phase 4 · 32 location(s) · Novartis Pharmaceuticals · NCT03340506Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Phase N/A · 7 location(s) · Alexion Pharmaceuticals, Inc. · NCT06312644A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain Metastases
NA · 2 location(s) · Attikon Hospital · NCT05564949Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)
Phase 2 · 2 location(s) · Peking University · NCT05165407
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.